2 not yet recruiting, 1 completed, 1 terminated, 1 withdrawn. 2 Not applicable, 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Terminated 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Raynaud Syndrome: new trials by email Literature Review of Raynaud Syndrome trials Research Report on Raynaud Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease BOTOX INJECTION - Buerger Disease, Raynaud Syndrome | Phase 3 | Not yet recruiting | University Hospital, Toulouse | 8 | 2027-01-01 | 2026-07-23 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Phototherapy For Treatment Of Raynaud's Phenomenon Blue Light Therapy, Sham Light Therapy - Raynaud Disease, Raynaud Phenomenon | Not applicable | Withdrawn | University of Minnesota | 2022-08-01 | 2023-01-06 | |
| Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena. gammaCore Sapphire, Sham Device - Raynaud Phenomenon, Primary Raynaud Phenomenon | Not applicable | Terminated | University of Toledo Health Science Campus | 6 | 2019-04-30 | 2025-07-15 |
| Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome vardenafil, Placebo - Raynaud Syndrome | Phase 2 / Phase 3 | Completed | University of Cologne | 57 | 2006-11-01 | 2011-02-08 |
Raynaud Disease (5) · Calciphylaxis (1) · Colitis, Ulcerative (1) · Craniocerebral Trauma (1) · Crohn Disease (1) · Enterocolitis, Pseudomembranous (1) · Epidermolysis Bullosa (1) · Frostbite (1) · Graft vs Host Disease (1) · Hypospadias (1) · Invasive Fungal Infections (1) · Multiple Sclerosis (1) · Myositis, Inclusion Body (1) · Optic Neuropathy, Ischemic (1) · Osteonecrosis (1)
Cardiovascular Diseases (5) · Embolism and Thrombosis (5) · Livedoid Vasculopathy (5) · Peripheral Vascular Diseases (5) · Skin Diseases (5) · Skin Diseases, Vascular (5) · Skin and Connective Tissue Diseases (5) · Thrombosis (5) · Vascular Diseases (5) · Arterial Occlusive Diseases (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bone Diseases (1)
Botulinum Toxins (1) · Oxygen (1) · Phototherapy (1) · Vardenafil Dihydrochloride (1)
Jay C. Buckey Jr. (1) · University Hospital, Toulouse (1) · University of Cologne (1) · University of Minnesota (1) · University of Toledo Health Science Campus (1)
United States (2) · France (1) · Germany (1)
Bashar Kahaleh, MD (1) · Jay Buckey (1) · Jerry Molitor, MD, PhD (1) · Julie Malloizel-Delaunay, MD (1) · Stephan Rosenkranz, MD (1)
2005 (1)